Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Italy15797815.6Filed on 2015-11-13
Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use United Kingdom15797815.6Filed on 2015-11-13
Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use France15797815.6Filed on 2015-11-13
Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Germany15797815.6Filed on 2015-11-13
Modified Anthrax Toxin Protective Antigen Read more about Modified Anthrax Toxin Protective Antigen United Kingdom16767065.2Filed on 2018-03-27
Modified Anthrax Toxin Protective Antigen Read more about Modified Anthrax Toxin Protective Antigen France16767065.2Filed on 2018-03-27
Modified Anthrax Toxin Protective Antigen Read more about Modified Anthrax Toxin Protective Antigen Germany16767065.2Filed on 2018-03-27
NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US Patent 11,760,794Filed on 2021-04-28
GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION Read more about GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US Application 17/224,819Filed on 2021-04-07
Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production Read more about Genetlically Stable Live Attenuated Respiratory Syncytial Virus Vaccine and its Production Norway19150800.1Filed on 2019-01-08